Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
NCT07530146 Propofol/Ketamine Hydrochloride Critical Illness Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
13 August 2026
NCT07530146 clinical trial report covering Propofol/Ketamine Hydrochloride, Phase 3, endpoints, sponsor, geography, readout timing and development white sp
Latest Hotspot
8 min read
CTR20261451 Epsametostat Peripheral T-Cell Lymphoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
13 August 2026
CTR20261451 clinical trial report covering Epsametostat, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07530640 Atorvastatin Calcium Coronary Artery Disease Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
13 August 2026
NCT07530640 clinical trial report covering Atorvastatin Calcium, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07530367 Tofacitinib Citrate Pustulosis of Palms and Soles Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
13 August 2026
NCT07530367 clinical trial report covering Tofacitinib Citrate, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07531043 Apraclonidine Hydrochloride Eye Redness Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
13 August 2026
NCT07531043 clinical trial report covering Apraclonidine Hydrochloride, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
CTR20261443 Benzoyl Peroxide/Tretinoin Acne Vulgaris Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
13 August 2026
CTR20261443 clinical trial report covering Benzoyl Peroxide/Tretinoin, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07533123 JSKN016 Triple Negative Breast Cancer Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
13 August 2026
NCT07533123 clinical trial report covering JSKN016, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
ChiCTR2600122711 Teplizumab Diabetes Mellitus, Type 1 Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
13 August 2026
ChiCTR2600122711 clinical trial report covering Teplizumab, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07533175 Zenagamtide Diabetes Mellitus, Type 2 Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
13 August 2026
NCT07533175 clinical trial report covering Zenagamtide, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07533747 Empagliflozin Coronary microvascular dysfunction Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
13 August 2026
NCT07533747 clinical trial report covering Empagliflozin, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
CTR20261249 Compound Caraway Enteric Liquid Capsule Abdominal Pain Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
13 August 2026
CTR20261249 clinical trial report covering Compound Caraway Enteric Liquid Capsule, Phase 3, endpoints, sponsor, geography, readout timing and development
Latest Hotspot
8 min read
CTR20261254 Compound Caraway Enteric Liquid Capsule Abdominal Pain Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
13 August 2026
CTR20261254 clinical trial report covering Compound Caraway Enteric Liquid Capsule, Phase 3, endpoints, sponsor, geography, readout timing and development